Literature DB >> 32649888

Cell Lineage-Based Stratification for Glioblastoma.

Zilai Wang1, Daochun Sun1, Yu-Jung Chen2, Xuanhua Xie1, Yufeng Shi1, Viviane Tabar3, Cameron W Brennan3, Tejus A Bale4, Chenura D Jayewickreme5, Dan R Laks1, Sheila Alcantara Llaguno1, Luis F Parada6.   

Abstract

Glioblastoma, the predominant adult malignant brain tumor, has been computationally classified into molecular subtypes whose functional relevance remains to be comprehensively established. Tumors from genetically engineered glioblastoma mouse models initiated by identical driver mutations in distinct cells of origin portray unique transcriptional profiles reflective of their respective lineage. Here, we identify corresponding transcriptional profiles in human glioblastoma and describe patient-derived xenografts with species-conserved subtype-discriminating functional properties. The oligodendrocyte lineage-associated glioblastoma subtype requires functional ERBB3 and harbors unique therapeutic sensitivities. These results highlight the importance of cell lineage in glioblastoma independent of driver mutations and provide a methodology for functional glioblastoma classification for future clinical investigations.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erbb3; GBM; PDX; cell of origin; glioblastoma; molecular classification; molecular subtype; mouse model; neural stem cell; oligodendrocyte lineage cell

Mesh:

Substances:

Year:  2020        PMID: 32649888      PMCID: PMC7494533          DOI: 10.1016/j.ccell.2020.06.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  69 in total

1.  BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis.

Authors:  Steffen Durinck; Yves Moreau; Arek Kasprzyk; Sean Davis; Bart De Moor; Alvis Brazma; Wolfgang Huber
Journal:  Bioinformatics       Date:  2005-08-15       Impact factor: 6.937

2.  Dasatinib in recurrent glioblastoma: failure as a teacher.

Authors:  David Schiff; Jann Sarkaria
Journal:  Neuro Oncol       Date:  2015-05-10       Impact factor: 12.300

3.  Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.

Authors:  Anna Segerman; Mia Niklasson; Caroline Haglund; Tobias Bergström; Malin Jarvius; Yuan Xie; Ann Westermark; Demet Sönmez; Annika Hermansson; Marianne Kastemar; Zeinab Naimaie-Ali; Frida Nyberg; Malin Berglund; Magnus Sundström; Göran Hesselager; Lene Uhrbom; Mats Gustafsson; Rolf Larsson; Mårten Fryknäs; Bo Segerman; Bengt Westermark
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

4.  Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.

Authors:  Yuan Zhu; Frantz Guignard; Dawen Zhao; Li Liu; Dennis K Burns; Ralph P Mason; Albee Messing; Luis F Parada
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

5.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

6.  Age-dependent fate and lineage restriction of single NG2 cells.

Authors:  Xiaoqin Zhu; Robert A Hill; Dirk Dietrich; Mila Komitova; Ryusuke Suzuki; Akiko Nishiyama
Journal:  Development       Date:  2011-02       Impact factor: 6.868

Review 7.  Glioma Subclassifications and Their Clinical Significance.

Authors:  Ricky Chen; Matthew Smith-Cohn; Adam L Cohen; Howard Colman
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

8.  A critical period for social experience-dependent oligodendrocyte maturation and myelination.

Authors:  Manabu Makinodan; Kenneth M Rosen; Susumu Ito; Gabriel Corfas
Journal:  Science       Date:  2012-09-14       Impact factor: 47.728

9.  Single-Cell Analysis of Regional Differences in Adult V-SVZ Neural Stem Cell Lineages.

Authors:  Dogukan Mizrak; Hanna Mendes Levitin; Ana C Delgado; Valerie Crotet; Jinzhou Yuan; Zayna Chaker; Violeta Silva-Vargas; Peter A Sims; Fiona Doetsch
Journal:  Cell Rep       Date:  2019-01-08       Impact factor: 9.423

10.  The integrated landscape of driver genomic alterations in glioblastoma.

Authors:  Veronique Frattini; Vladimir Trifonov; Joseph Minhow Chan; Angelica Castano; Marie Lia; Francesco Abate; Stephen T Keir; Alan X Ji; Pietro Zoppoli; Francesco Niola; Carla Danussi; Igor Dolgalev; Paola Porrati; Serena Pellegatta; Adriana Heguy; Gaurav Gupta; David J Pisapia; Peter Canoll; Jeffrey N Bruce; Roger E McLendon; Hai Yan; Ken Aldape; Gaetano Finocchiaro; Tom Mikkelsen; Gilbert G Privé; Darell D Bigner; Anna Lasorella; Raul Rabadan; Antonio Iavarone
Journal:  Nat Genet       Date:  2013-08-05       Impact factor: 38.330

View more
  17 in total

Review 1.  A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care.

Authors:  Ahmed Habib; Matthew Pease; Chowdari V Kodavali; Nduka Amankulor; Pascal O Zinn
Journal:  J Neurooncol       Date:  2021-01-04       Impact factor: 4.130

2.  Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy.

Authors:  Xuanhua P Xie; Dan R Laks; Daochun Sun; Mungunsarnai Ganbold; Zilai Wang; Alicia M Pedraza; Tejus Bale; Viviane Tabar; Cameron Brennan; Xiuping Zhou; Luis F Parada
Journal:  Dev Cell       Date:  2022-01-10       Impact factor: 12.270

Review 3.  Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.

Authors:  Ryan C Gimple; Kailin Yang; Matthew E Halbert; Sameer Agnihotri; Jeremy N Rich
Journal:  Nat Rev Cancer       Date:  2022-06-16       Impact factor: 69.800

4.  High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML.

Authors:  Paula Aldaz; Natalia Martín-Martín; Ander Saenz-Antoñanzas; Estefania Carrasco-Garcia; María Álvarez-Satta; Alejandro Elúa-Pinin; Steven M Pollard; Charles H Lawrie; Manuel Moreno-Valladares; Nicolás Samprón; Jürgen Hench; Robin Lovell-Badge; Arkaitz Carracedo; Ander Matheu
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

Review 5.  Systems neuroimmunology: a review of multiomics methodologies to characterize neuroimmunological interactions in spinal and cranial diseases.

Authors:  Cameron Zamanian; Archis R Bhandarkar; Dileep D Monie; F M Moinuddin; Richard G Vile; Alfredo Quiñones-Hinojosa; Mohamad Bydon
Journal:  Neurosurg Focus       Date:  2022-02       Impact factor: 4.332

Review 6.  Genetic Architectures and Cell-of-Origin in Glioblastoma.

Authors:  Hyun Jung Kim; Jung Won Park; Jeong Ho Lee
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

7.  The GAUGAA Motif Is Responsible for the Binding between circSMARCA5 and SRSF1 and Related Downstream Effects on Glioblastoma Multiforme Cell Migration and Angiogenic Potential.

Authors:  Davide Barbagallo; Angela Caponnetto; Cristina Barbagallo; Rosalia Battaglia; Federica Mirabella; Duilia Brex; Michele Stella; Giuseppe Broggi; Roberto Altieri; Francesco Certo; Rosario Caltabiano; Giuseppe Maria Vincenzo Barbagallo; Carmelina Daniela Anfuso; Gabriella Lupo; Marco Ragusa; Cinzia Di Pietro; Thomas Birkballe Hansen; Michele Purrello
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

Review 8.  Overcoming TRAIL Resistance for Glioblastoma Treatment.

Authors:  Longfei Deng; Xuan Zhai; Ping Liang; Hongjuan Cui
Journal:  Biomolecules       Date:  2021-04-14

9.  Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma.

Authors:  Minjie Fu; Jinsen Zhang; Weifeng Li; Shan He; Jingwen Zhang; Daniel Tennant; Wei Hua; Ying Mao
Journal:  J Transl Med       Date:  2021-09-26       Impact factor: 5.531

10.  Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma.

Authors:  Qi Wang; Yang Zhang; Bolei Zhang; Yao Fu; Xiaozhi Zhao; Jing Zhang; Ke Zuo; Yuexian Xing; Song Jiang; Zhaohui Qin; Erguang Li; Hongqian Guo; Zhihong Liu; Jingping Yang
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.